Ha habido 50 transacciones internas recientes registradas para Fulcrum Therapeutics, Inc. (FULC), incluyendo 34 compras y 14 ventas. El total de compras internas fue valorado en $29.23M y el total de ventas internas en $10.1M.
Internos destacados con actividad reciente incluyen Musso Alan A, Gould Robert J, Sapir Alex. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — FULC
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-02-02 |
Musso Alan A |
Chief Financial Officer |
Concesión de RSU |
170,000 |
$10.72 |
$1.82M |
170,000 |
| 2026-02-02 |
Gould Robert J |
Director |
Venta Informativa |
15,000 |
$10.72 |
$160.86K |
454,864 |
| 2026-02-02 |
Sapir Alex |
See Remarks |
Concesión de RSU |
650,000 |
$10.72 |
$6.97M |
650,000 |
| 2026-02-02 |
Oltmans Curtis Gale |
Chief Legal Officer |
Concesión de RSU |
170,000 |
$10.72 |
$1.82M |
170,000 |
| 2026-02-02 |
Tourangeau Greg |
Principal Accounting Officer |
Concesión de RSU |
57,000 |
$10.72 |
$611.04K |
57,000 |
| 2026-01-02 |
Gould Robert J |
Director |
Venta Informativa |
15,000 |
$11.87 |
$178.09K |
469,864 |
| 2026-01-02 |
Gould Robert J |
Director |
Venta Informativa |
15,000 |
$10.87 |
$163.09K |
469,864 |
| 2025-12-15 |
Oltmans Curtis Gale |
Chief Legal Officer |
Venta Informativa |
3,452 |
$12.92 |
$44.6K |
10,252 |
| 2025-12-08 |
Ra Capital Management, L.p. |
10 Percent Owner |
Venta Informativa |
91,722 |
$14.98 |
$1.37M |
6,053,960 |
| 2025-11-19 |
Gould Robert J |
Director |
Venta Informativa |
15,000 |
$11.03 |
$165.5K |
484,864 |
| 2025-06-26 |
Geraghty James A |
Director |
Concesión de RSU |
36,000 |
$7.38 |
$265.68K |
36,000 |
| 2025-06-26 |
Gould Robert J |
Director |
Concesión de RSU |
36,000 |
$7.38 |
$265.68K |
36,000 |
| 2025-06-26 |
King Rachel K. |
Director |
Concesión de RSU |
36,000 |
$7.38 |
$265.68K |
36,000 |
| 2025-06-26 |
Dorton Katina |
Director |
Concesión de RSU |
36,000 |
$7.38 |
$265.68K |
36,000 |
| 2025-06-26 |
Haviland Kate |
Director |
Concesión de RSU |
36,000 |
$7.38 |
$265.68K |
36,000 |
| 2025-06-26 |
Hill Colin |
Director |
Concesión de RSU |
36,000 |
$7.38 |
$265.68K |
36,000 |
| 2025-06-26 |
Ezekowitz Alan |
Director |
Concesión de RSU |
36,000 |
$7.38 |
$265.68K |
36,000 |
| 2025-06-26 |
Banks Sonja |
Director |
Concesión de RSU |
36,000 |
$7.38 |
$265.68K |
36,000 |
| 2025-05-08 |
Tourangeau Greg |
Principal Accounting Officer |
Venta Informativa |
498 |
$5.06 |
$2.52K |
14,062 |
| 2025-01-24 |
Musso Alan A |
Chief Financial Officer |
Concesión de RSU |
285,000 |
$4.16 |
$1.19M |
285,000 |
| 2025-01-24 |
Sapir Alex |
See Remarks |
Concesión de RSU |
582,000 |
$4.16 |
$2.42M |
582,000 |
| 2025-01-24 |
Oltmans Curtis Gale |
Chief Legal Officer |
Concesión de RSU |
225,000 |
$4.16 |
$936K |
225,000 |
| 2025-01-24 |
Tourangeau Greg |
Principal Accounting Officer |
Concesión de RSU |
76,120 |
$4.16 |
$316.66K |
76,120 |
| 2024-11-12 |
King Rachel K. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-11-12 |
King Rachel K. |
Director |
Concesión de RSU |
60,000 |
$3.64 |
$218.4K |
60,000 |
| 2024-09-12 |
Ra Capital Management, L.p. |
10 Percent Owner |
Desconocido |
8,500,000 |
$0.00 |
$8.5K |
- |
| 2024-08-21 |
Ra Capital Management, L.p. |
10 Percent Owner |
Otro (Venta) |
8,500,000 |
$0.00 |
$8.5K |
3,109,704 |
| 2024-07-03 |
Sapir Alex |
See Remarks |
Ejercicio de Opciones |
150,000 |
$3.27 |
$490.5K |
193,360 |
| 2024-06-17 |
Geraghty James A |
Director |
Concesión de RSU |
30,000 |
$7.00 |
$210K |
30,000 |
| 2024-06-17 |
Gould Robert J |
Director |
Concesión de RSU |
30,000 |
$7.00 |
$210K |
30,000 |
| 2024-06-17 |
Dorton Katina |
Director |
Concesión de RSU |
30,000 |
$7.00 |
$210K |
30,000 |
| 2024-06-17 |
Haviland Kate |
Director |
Concesión de RSU |
30,000 |
$7.00 |
$210K |
30,000 |
| 2024-06-17 |
Hill Colin |
Director |
Disposición |
- |
- |
- |
- |
| 2024-06-17 |
Hill Colin |
Director |
Concesión de RSU |
60,000 |
$7.00 |
$420K |
60,000 |
| 2024-06-17 |
Collins James J. |
Director |
Concesión de RSU |
30,000 |
$7.00 |
$210K |
30,000 |
| 2024-06-17 |
Ezekowitz Alan |
Director |
Concesión de RSU |
30,000 |
$7.00 |
$210K |
30,000 |
| 2024-06-17 |
Banks Sonja |
Director |
Concesión de RSU |
30,000 |
$7.00 |
$210K |
30,000 |
| 2024-05-07 |
Tourangeau Greg |
Principal Accounting Officer |
Venta Informativa |
236 |
$7.76 |
$1.83K |
11,571 |
| 2024-03-18 |
Horn Patrick Taylor |
Chief Medical Officer |
Disposición |
- |
- |
- |
- |
| 2024-03-18 |
Horn Patrick Taylor |
Chief Medical Officer |
Concesión de RSU |
400,000 |
$10.12 |
$4.05M |
400,000 |
| 2024-03-08 |
Tourangeau Greg |
Vice President, Finance |
Venta Informativa |
4,884 |
$11.72 |
$57.22K |
11,807 |
| 2024-03-04 |
Sapir Alex |
See Remarks |
Compra Informativa |
43,360 |
$11.35 |
$492.03K |
43,360 |
| 2024-01-26 |
Musso Alan A |
Chief Financial Officer |
Concesión de RSU |
100,000 |
$6.95 |
$695K |
100,000 |
| 2024-01-26 |
Oltmans Curtis Gale |
Chief Legal Officer |
Concesión de RSU |
150,000 |
$6.95 |
$1.04M |
150,000 |
| 2024-01-26 |
Tourangeau Greg |
Vice President, Finance |
Concesión de RSU |
10,000 |
$6.95 |
$69.5K |
10,000 |
| 2024-01-17 |
Musso Alan A |
Chief Financial Officer |
Concesión de RSU |
61,822 |
$4.01 |
$247.91K |
61,822 |
| 2023-08-07 |
Musso Alan A |
Chief Financial Officer |
Disposición |
- |
- |
- |
- |
| 2023-08-07 |
Musso Alan A |
Chief Financial Officer |
Concesión de RSU |
432,800 |
$4.01 |
$1.74M |
432,800 |
| 2023-07-01 |
Sapir Alex |
See Remarks |
Disposición |
2,430,400 |
$3.27 |
$7.95M |
- |
| 2023-06-27 |
Geraghty James A |
Director |
Concesión de RSU |
30,000 |
$3.16 |
$94.8K |
30,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
